MENU
DYN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Dyne Therapeutics (DYN) Earnings Date & Reports

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases... Show more

A.I. Advisor
published Earnings

DYN is expected to report earnings to rise 10.04% to -83 cents per share on February 26

Dyne Therapeutics DYN Stock Earnings Reports
Q4'25
Est.
$-0.84
Q3'25
Beat
by $0.08
Q2'25
Missed
by $0.03
Q1'25
Missed
by $0.20
Q4'24
Beat
by $0.06
The last earnings report on November 05 showed earnings per share of -75 cents, beating the estimate of -83 cents. With 670.30K shares outstanding, the current market capitalization sits at 2.66B.
View a ticker or compare two or three
DYN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. DYN showed earnings on November 05, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Electric Utilities
Address
1560 Trapelo Road
Phone
+1 781 786-8230
Employees
141
Web
https://www.dyne-tx.com